Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Wegener's granulomatosis: is biologic therapy useful?

Sarraf P, Kay J, Friday RP, Reginato AM.

Curr Rheumatol Rep. 2006 Aug;8(4):303-11. Review.

PMID:
16839510
2.

Design of the Wegener's Granulomatosis Etanercept Trial (WGET).

WGET Research Group.

Control Clin Trials. 2002 Aug;23(4):450-68.

PMID:
12161090
3.

Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.

Seo P, Specks U, Keogh KA.

J Rheumatol. 2008 Oct;35(10):2017-23. Epub 2008 Aug 1.

PMID:
18688911
4.

Pathogenesis of Wegener's granulomatosis: current concepts.

Sarraf P, Sneller MC.

Expert Rev Mol Med. 2005 May 13;7(8):1-19. Review.

PMID:
15890083
5.

Treatment of Wegener's granulomatosis.

Regan MJ, Hellmann DB, Stone JH.

Rheum Dis Clin North Am. 2001 Nov;27(4):863-86, viii. Review.

PMID:
11723769
6.

Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.

Metzler C, Miehle N, Manger K, Iking-Konert C, de Groot K, Hellmich B, Gross WL, Reinhold-Keller E; German Network of Rheumatic Diseases.

Rheumatology (Oxford). 2007 Jul;46(7):1087-91. Epub 2007 May 22.

PMID:
17519271
7.

Biological therapies: new treatment options for ANCA-associated vasculitis?

Aries PM, Lamprecht P, Gross WL.

Expert Opin Biol Ther. 2007 Apr;7(4):521-33. Review.

PMID:
17373903
8.

Pharmacological therapy for Wegener's granulomatosis.

White ES, Lynch JP.

Drugs. 2006;66(9):1209-28. Review.

9.

A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis.

Stone JH, Rajapakse VN, Hoffman GS, Specks U, Merkel PA, Spiera RF, Davis JC, St Clair EW, McCune J, Ross S, Hitt BA, Veenstra TD, Conrads TP, Liotta LA, Petricoin EF 3rd; Wegener's Granulomatosis Etanercept Trial Research Group.

Arthritis Rheum. 2005 Mar;52(3):902-10.

10.

Wegener's granulomatosis.

Hoffman GS.

Curr Opin Rheumatol. 1993 Jan;5(1):11-7. Review.

PMID:
8435284
11.

Predictors at diagnosis of a first Wegener's granulomatosis relapse after obtaining complete remission.

Pierrot-Deseilligny Despujol C, Pouchot J, Pagnoux C, Coste J, Guillevin L.

Rheumatology (Oxford). 2010 Nov;49(11):2181-90. doi: 10.1093/rheumatology/keq244. Epub 2010 Jul 31.

PMID:
20675708
12.

Drug insight: anti-tumor necrosis factor therapies for the vasculitic diseases.

Langford CA.

Nat Clin Pract Rheumatol. 2008 Jul;4(7):364-70. doi: 10.1038/ncprheum0825. Epub 2008 May 27. Review.

PMID:
18506159
13.

Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis.

Bachmeyer C, Cadranel JF, Demontis R.

Nephrol Dial Transplant. 2005 Jun;20(6):1274. Epub 2005 Apr 19. No abstract available.

PMID:
15840659
14.

Recurrence of Wegener's granulomatosis with de novo intraoral presentation treated successfully with rituximab.

Staines KS, Higgins B.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jul;108(1):76-80. doi: 10.1016/j.tripleo.2009.02.025. Epub 2009 May 17.

PMID:
19451001
15.

Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.

Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS.

Medicine (Baltimore). 2007 Sep;86(5):269-77.

16.

Therapeutics of Wegener's granulomatosis.

Wung PK, Stone JH.

Nat Clin Pract Rheumatol. 2006 Apr;2(4):192-200. Review.

PMID:
16932685
17.

Wegener's granulomatosis: managing more than inflammation.

Seo P.

Curr Opin Rheumatol. 2008 Jan;20(1):10-6. doi: 10.1097/BOR.0b013e3282f18bef. Review.

PMID:
18281851
18.

Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects.

Aouba A, Pagnoux C, Bienvenu B, Mahr A, Guillevin L.

Clin Rev Allergy Immunol. 2008 Feb;34(1):65-73. doi: 10.1007/s12016-007-8026-1. Epub 2007 Sep 12.

PMID:
18270860
19.

Wegener's granulomatosis: current and upcoming therapies.

Langford CA.

Arthritis Res Ther. 2003;5(4):180-91. Epub 2003 May 29. Review.

20.

Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Lee RW, D'Cruz DP.

Drugs. 2008;68(6):747-70. Review.

PMID:
18416584

Supplemental Content

Support Center